Gene · 5313
NIH grants1,543
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,543
Download this page as JSON| Grant | Title | PKLR papers | Newest fiscal year |
|---|---|---|---|
| ZIABC011459 | Control of centrosome biogenesis | 1 | 2025 |
| ZIABC011652 | Precision Therapy to Target Pancreatic Ductal Adenocarcinoma | 1 | 2025 |
| ZIACL090052 | Neurobiology of pain and behavior changes associated with rare diseases and developmental disabilities | 1 | 2025 |
| ZIACL090053 | Pathobiology of pain in sickle cell disease | 1 | 2025 |
| ZIADC000039 | Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment | 1 | 2025 |
| ZIADC000048 | Functional Studies of "Deafness Genes" Essential for Hearing | 1 | 2025 |
| ZIADK029053 | Sickle cell disease molecular pathogenesis and drug therapy | 1 | 2025 |
| ZIADK075013 | Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy | 1 | 2025 |
| ZIAES100485 | Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3 | 1 | 2025 |
| ZIAES101586 | Nuclear receptors: action, functions, and roles in disease | 1 | 2025 |
| ZIAES103166 | DNA Microarray Data Analysis | 1 | 2025 |
| ZIAEY000450 | Genetic and epigenetic regulation of retinal development, aging and evolution | 1 | 2025 |
| ZIAEY000490 | Disease mechanism and therapies for retinal degeneration | 1 | 2025 |
| ZIAEY000546 | Mechanisms, modeling and therapies of retinal and macular neurodegeneration | 1 | 2025 |
| ZIAHL006233 | Studies of the Natural History of Sickle Cell Disease | 1 | 2025 |
| ZIAHL006240 | Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease | 1 | 2025 |
| ZIASC010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses | 1 | 2025 |
| ZIASC010384 | Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency | 1 | 2025 |
| ZICES102445 | Gene Expression and Microarrays | 1 | 2025 |
| ZICHL006019 | Light Microscopy Core | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/grants?page=16